{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:26:08Z","timestamp":1791343568032,"version":"4.3.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["P41 RR001081"],"award-info":[{"award-number":["P41 RR001081"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["R24GM154185"],"award-info":[{"award-number":["R24GM154185"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1170236"],"award-info":[{"award-number":["OPP1170236"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-004923"],"award-info":[{"award-number":["INV-004923"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["75A50120C00034"],"award-info":[{"award-number":["75A50120C00034"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 AI127521"],"award-info":[{"award-number":["R01 AI127521"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["UM1 AI144462"],"award-info":[{"award-number":["UM1 AI144462"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016820","name":"Vaccine Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021704","name":"Administration for Strategic Preparedness and Response","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.celrep.2025.115986","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:00:59Z","timestamp":1751954459000},"page":"115986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7994-4693","authenticated-orcid":false,"given":"Sandhya","family":"Bangaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Copps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Fern\u00e1ndez-Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Richey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartek","family":"Nogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh M.","family":"Sewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Torrents de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Guebre-Xabier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kizzmekia S.","family":"Corbett-Helaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Seder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin K.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gale","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":false,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.115986_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.115986_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chom.2021.06.016","article-title":"The success of SARS-CoV-2 vaccines and challenges ahead","volume":"29","author":"Subbarao","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.115986_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(23)00140-6","article-title":"COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint","volume":"11","author":"Zaeck","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41591-023-02219-5","article-title":"Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population","volume":"29","author":"Lau","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMsr2105280","article-title":"SARS-CoV-2 Variants and Vaccines","volume":"385","author":"Krause","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A Bivalent Omicron-Containing Booster Vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib7","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S1473-3099(23)00746-6","article-title":"Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study","volume":"24","author":"Hansen","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2025.115986_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj9945","article-title":"Waning immunity and IgG4 responses following bivalent mRNA boosting","volume":"10","author":"Lasrado","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.115986_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S2213-2600(23)00306-5","article-title":"Effectiveness of BNT162b2 BA.4\/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study","volume":"11","author":"Tartof","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(22)00055-1","article-title":"Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial","volume":"399","author":"Bravo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2025.115986_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5449","article-title":"Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates","volume":"13","author":"Darricarrere","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib14","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.cell.2022.04.029","article-title":"Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2","volume":"185","author":"Xu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6502","article-title":"Vaccination induces HIV broadly neutralizing antibody precursors in humans","volume":"378","author":"Leggat","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.115986_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-021-00523-5","article-title":"SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2025.115986_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115986_bib21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX : Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2025.115986_bib24","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1172\/JCI141206","article-title":"Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization","volume":"130","author":"Salazar","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115986_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2025.115986_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115986_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2020.10.012","article-title":"Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies","volume":"538","author":"Yuan","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115986_bib30","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1080\/22221751.2022.2125348","article-title":"Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies","volume":"11","author":"Huang","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.115986_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115986_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","volume":"29","author":"Cerutti","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.115986_bib34","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib36","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.chom.2023.05.016","article-title":"Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses","volume":"31","author":"Dacon","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.115986_bib38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.abq3773","article-title":"Broadly neutralizing antibodies target the coronavirus fusion peptide","volume":"377","author":"Dacon","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abq2679","article-title":"ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies","volume":"377","author":"Low","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2023.02.005","article-title":"Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease","volume":"56","author":"Zhou","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115986_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi9215","article-title":"A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection","volume":"14","author":"Zhou","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00965-21","article-title":"High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients","volume":"9","author":"Nitahara","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.celrep.2025.115986_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib45","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220826","article-title":"Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens","volume":"219","author":"Wang","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115986_bib47","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1038\/s41467-021-25087-4","article-title":"Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM","volume":"12","author":"Antanasijevic","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.celrep.2025.115986_bib49","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.abe1502","article-title":"Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate","volume":"370","author":"Bangaru","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib50","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib51","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib52","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1016\/j.vaccine.2020.10.064","article-title":"NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge","volume":"38","author":"Guebre-Xabier","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.115986_bib53","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMc2102179","article-title":"Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine","volume":"384","author":"Wu","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-024-00806-2","article-title":"Three immunizations with Novavax\u2019s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2","volume":"9","author":"Lenart","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2025.115986_bib55","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","article-title":"Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses","volume":"55","author":"Tas","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115986_bib56","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/s41467-020-19146-5","article-title":"Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein","volume":"11","author":"Wrobel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.chom.2020.07.002","article-title":"Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.115986_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00480-22","article-title":"Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer","volume":"96","author":"Zhan","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.115986_bib59","article-title":"Increasing sensitivity of antibody-antigen interactions using photo-cross-linking","volume":"3","author":"Pena","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.celrep.2025.115986_bib60","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.immuni.2022.04.003","article-title":"Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115986_bib62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115986_bib63","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.abm5835","article-title":"SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies","volume":"375","author":"Reincke","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib64","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-022-35606-6","article-title":"Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants","volume":"14","author":"Logue","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.chom.2021.11.013","article-title":"The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants","volume":"30","author":"Liu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.115986_bib66","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41422-021-00514-9","article-title":"Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines","volume":"31","author":"Cao","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2025.115986_bib67","article-title":"Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality","author":"Goike","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2025.115986_bib68","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.cell.2021.05.032","article-title":"An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib69","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib70","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115986_bib71","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/s41467-021-22926-2","article-title":"A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes","volume":"12","author":"Guo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114307","article-title":"Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes","volume":"43","author":"Hurtado","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.115986_bib73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","article-title":"Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost","volume":"607","author":"Muecksch","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115986_bib74","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220732","article-title":"Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans","volume":"219","author":"Cho","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.115986_bib75","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/s41467-021-24514-w","article-title":"Potent and protective IGHV3-53\/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115986_bib76","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jinf.2022.10.015","article-title":"Germline variants of IGHV3-53\/V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine","volume":"85","author":"Mashimo","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.celrep.2025.115986_bib77","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.abg5268","article-title":"Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes","volume":"372","author":"Voss","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115986_bib78","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159062","article-title":"An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer","volume":"132","author":"Suryadevara","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115986_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109928","article-title":"Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain","volume":"37","author":"Cerutti","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.115986_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn2911","article-title":"Structural mapping of antibody landscapes to human betacoronavirus spike proteins","volume":"8","author":"Bangaru","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.115986_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.115986_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsb.2009.01.004","article-title":"DoG Picker and TiltPicker: Software tools to facilitate particle selection in single particle electron microscopy","volume":"166","author":"Voss","year":"2009","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.115986_bib84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsb.2009.01.002","article-title":"Appion: An integrated, database-driven pipeline to facilitate EM image processing","volume":"166","author":"Lander","year":"2009","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.115986_bib85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.115986_bib86","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.celrep.2025.115986_bib87","doi-asserted-by":"crossref","DOI":"10.1063\/5.0012280","article-title":"CHARMM-GUI supports the Amber force fields","volume":"153","author":"Lee","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.celrep.2025.115986_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003769","article-title":"Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial","volume":"18","author":"Formica","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2025.115986_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102476","article-title":"Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping","volume":"4","author":"Turner","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.celrep.2025.115986_bib90","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.115986_bib91","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115986_bib92","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.115986_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"Zhang","year":"2016","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.115986_bib94","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35560","article-title":"Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size","volume":"7","author":"El Hage","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.115986_bib95","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.celrep.2025.115986_bib96","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/ct400626b","article-title":"Quantifying Artifacts in Ewald Simulations of Inhomogeneous Systems with a Net Charge","volume":"10","author":"Hub","year":"2014","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.celrep.2025.115986_bib97","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1021\/jp101654g","article-title":"Stabilizing of a globular protein by a highly complex water network: a molecular dynamics simulation study on factor Xa","volume":"114","author":"Wallnoefer","year":"2010","journal-title":"J. Phys. Chem. B"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725007570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725007570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:58:11Z","timestamp":1786219091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725007570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2211124725007570"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115986","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.11.628030","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115986"}}